An exploratory PET/MR radiomics framework for preoperative prediction of HER2 status and metastatic burden in colorectal cancer
Introduction: Noninvasive assessment of human epidermal growth factor receptor 2 (HER2) status and metastatic burden in colorectal cancer remains challenging. Multimodal positron emission tomography (PET)/magnetic resonance (MR) radiomics offers an opportunity for integrated molecular and metastatic characterization.
Objective: To develop and internally validate an exploratory PET/MR radiomics framework for the preoperative prediction of HER2 status and metastatic burden (non-regional lymph nodes) in colorectal cancer (CRC) patients.
Methods: This retrospective study incorporated 61 samples with pathologically confirmed CRC who underwent preoperative 18F-fluorodeoxyglucose PET/MR imaging. HER2 positivity was defined according to the refined HER2 Amplification for CRC Enhanced Stratification criteria. Metastatic burden was categorized into three groups based on preoperative imaging: non-metastatic, regional lymph node metastasis, and distant metastasis. Tumor regions were manually segmented on PET, T1- and T2-weighted imaging (T1WI, T2WI), and 2,264 radiomic features were extracted from each imaging modality. Feature selection was performed using a comprehensive multi-step pipeline. An extreme gradient boosting (XGBoost)-based model was then developed and internally validated via 5-fold cross-validation, with performance metrics reported as mean ± standard deviation.
Results: For HER2 status prediction, the multimodal combined XGBoost model demonstrated superior performance compared to single-modality models, yielding a mean AUC of 0.9214 ± 0.0779. For metastatic burden prediction, the combined model further excelled, yielding an AUC of 0.827 ± 0.136. SHapley Additive exPlanations analysis revealed imaging signatures for the two prediction tasks. HER2 status prediction was primarily driven by texture-related features, particularly those derived from the Gray-Level Run Length Matrix, Gray-Level Co-occurrence Matrix, and First-order matrices, whereas metastatic burden prediction relied mainly on multiscale texture descriptors from the first-order, Neighborhood Gray-Tone Difference Matrix, and Gray-Level Dependence Matrix.
Conclusion: PET/MR radiomics offers an exploratory approach for future risk stratification in CRC, although independent validation is required to confirm clinical utility.
- Chen N, He L, Zou Q, Deng H. HER2 targeted therapy in colorectal Cancer: Current landscape and future directions. Biochem Pharmacol. 2024;223:116101. doi: 10.1016/j.bcp.2024.116101
- Zhang R, Su C, Jia Y, Xing M, Jin S, Zong H. Molecular mechanisms of HER2-targeted therapy and strategies to overcome the drug resistance in colorectal cancer. Biomed Pharmacother. 2024;179:117363. doi: 10.1016/j.biopha.2024.117363
- Takegawa N, Yonesaka K. HER2 as an Emerging Oncotarget for Colorectal Cancer Treatment After Failure of Anti-Epidermal Growth Factor Receptor Therapy. Clin Colorectal Cancer. 2017;16:247-251. doi: 10.1016/j.clcc.2017.03.001
- Guarini C, Grassi T, Pezzicoli G, Porta C. Beyond RAS and BRAF: HER2, a New Actionable Oncotarget in Advanced Colorectal Cancer. Int J Mol Sci. 2021;22(13):6813. doi: 10.3390/ijms22136813
- Yoshikawa A, Nakamura Y. Molecular Basis of HER2-Targeted Therapy for HER2-Positive Colorectal Cancer. Cancers. 2022;15(1):183. doi: 10.3390/cancers15010183
- Jin M, Frankel WL. Lymph Node Metastasis in Colorectal Cancer. Surg Oncol Clin N Am. 2018;27(2):401-412. doi: 10.1016/j.soc.2017.11.011
- Lee DH, Lee JM. Whole-body PET/MRI for colorectal cancer staging: Is it the way forward? J Magn Reson Imaging. 2017;45(1):21-35. doi: 10.1002/jmri.25337
- Fraum TJ, Owen JW, Fowler KJ. Beyond Histologic Staging: Emerging Imaging Strategies in Colorectal Cancer with Special Focus on Magnetic Resonance Imaging. Clin Colon Rectal Surg. 2016;29(3):205-215. doi: 10.1055/s-0036-1584288
- Shen G, Hu S, Liu B, Kuang A. Diagnostic Performance of Whole-Body PET/MRI for Detecting Malignancies in Cancer Patients: A Meta-Analysis. PLoS ONE. 2016;11(4):e0154497. doi: 10.1371/journal.pone.0154497
- Guglielmo P, Marturano F, Bettinelli A, Gregianin M, Paiusco M, Evangelista L. Additional Value of PET Radiomic Features for the Initial Staging of Prostate Cancer: A Systematic Review from the Literature. Cancers. 2021;13(23):6026. doi: 10.3390/cancers13236026
- Vuong D, Tanadini-Lang S, Huellner MW, et al. Interchangeability of radiomic features between [18F]-FDG PET/CT and [18F]-FDG PET/MR. Med Phys. 2019;46(4):1677-1685. doi: 10.1002/mp.13422
- Palumbo B, Bianconi F, Palumbo I, et al. Value of Shape and Texture Features from 18F-FDG PET/CT to Discriminate between Benign and Malignant Solitary Pulmonary Nodules: An Experimental Evaluation. Diagnostics. 2020;10(9):696. doi: 10.3390/diagnostics10090696
- Zhao Q, Shi C-Z, Luo L-P. Role of the texture features of images in the diagnosis of solitary pulmonary nodules in different sizes. Chin J Cancer Res. 2014;26:451-458. doi: 10.3978/j.issn.1000-9604.2014.08.07
- Vallières M, Freeman CR, Skamene SR, El Naqa I. A radiomics model from joint FDG-PET and MRI texture features for the prediction of lung metastases in soft-tissue sarcomas of the extremities. Phys Med Biol. 2015;60(4):5471-5496. doi: 10.1088/0031-9155/60/14/5471
- Mirshahvalad SA, Hinzpeter R, Kohan A, et al. Diagnostic performance of [18F]-FDG PET/MR in evaluating colorectal cancer: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging. 2022;49(12):4205-4217. doi: 10.1007/s00259-022-05871-0
- Feng L, Liu Z, Li C, et al. Development and validation of a radiopathomics model to predict pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicentre observational study. Lancet Digit Health. 2022;4(1):e8-e17. doi: 10.1016/S2589-7500(21)00215-6
- Xue T, Peng H, Chen Q, Li M, Duan S, Feng F. Preoperative prediction of KRAS mutation status in colorectal cancer using a CT-based radiomics nomogram. Br J Radiol. 2022;95(1134):20211014. doi: 10.1259/bjr.20211014
- Xue T, Peng H, Chen Q, Li M, Duan S, Feng F. Preoperative Prediction of BRAF Mutation Status in Colorectal Cancer Using a Clinical-radiomics Model. Acad Radiol. 2022;29(9):1298-1307. doi: 10.1016/j.acra.2021.12.016
- Golia Pernicka JS, Gagniere J, Chakraborty J, et al. Radiomics-based prediction of microsatellite instability in colorectal cancer at initial computed tomography evaluation. Abdom Radiol (NY). 2019;44(11):3755-3763. doi: 10.1007/s00261-019-02117-w
- Wang H, Chen X, Ding J, et al. Novel multiparametric MRI-based radiomics in preoperative prediction of perirectal fat invasion in rectal cancer. Abdom Radiol (NY). 2023;48(2):471-485. doi: 10.1007/s00261-022-03759-z
- Valtorta E, Martino C, Sartore-Bianchi A, et al. Assessment of a HER2 scoring system for colorectal cancer: results from a validation study. Mod Pathol. 2015;28(11):1481-1491. doi: 10.1038/modpathol.2015.98
- Oliva MR, Saini S. Liver cancer imaging: role of CT, MRI, US and PET. Cancer Imaging. 2004;4(suppl A):S42-S46. doi: 10.1102/1470-7330.2004.0011
- Nioche C, Orlhac F, Boughdad S, et al. LIFEx: A Freeware for Radiomic Feature Calculation in Multimodality Imaging to Accelerate Advances in the Characterization of Tumor Heterogeneity. Cancer Res. 2018;78(16):4786-4789. doi: 10.1158/0008-5472.CAN-18-0125
- Zhang Y, Zhou X, Li P, Li C, Ke L. XGBoost-based model for predicting five-year survival in gastric cancer using clinical indicators. Sci Rep. 2026;16(1). doi: 10.1038/s41598-026-50043-x
- Li T, Qi W, Mao X, et al. Prediction of lumbar disc degeneration based on interpretable machine learning models: retrospective cohort study. Spine J. 2025;25(10):2335-2348. doi: 10.1016/j.spinee.2025.04.004
- Seto H, Oyama A, Kitora S, et al. Gradient boosting decision tree becomes more reliable than logistic regression in predicting probability for diabetes with big data. Sci Rep. 2022;12(1):15889. doi: 10.1038/s41598-022-20149-z
- Srisuradetchai P, Suksrikran K. Random kernel k-nearest neighbors regression. Front Big Data. 2024;7:1402384. doi: 10.3389/fdata.2024.1402384
- Narayanan H, Sokolov M, Butté A, Morbidelli M. Decision Tree-PLS (DT-PLS) algorithm for the development of process: Specific local prediction models. Biotechnol Prog. 2019;35(4). doi: 10.1002/btpr.2818
- Luo X, Wen X, Zhou M, Abusorrah A, Huang L. Decision-Tree-Initialized Dendritic Neuron Model for Fast and Accurate Data Classification. IEEE Trans Neural Netw Learn Syst. 2022;33(9):4173-4183. doi: 10.1109/TNNLS.2021.3055991
- Lubiński J, Lener MR, Marciniak W, et al. Serum Essential Elements and Survival after Cancer Diagnosis. Nutrients. 2023;15(11):2611. doi: 10.3390/nu15112611
